





ISPE Supply Chain Conference Programme Leaders:
| 09.00 - 09.20 |
Introductions and Announcements; |
||||||||||||
| 09.20 - 10.00 |
Keynote Presentation followed by Q&A Session |
||||||||||||
| 10.00 - 10.40 |
Keynote Presentation followed by Q&A Session |
||||||||||||
| 10.40 - 11.10 | Networking Break | ||||||||||||
| CLINICAL SUPPLY CHAIN | COMMERCIAL SUPPLY CHAIN | ||||||||||||
| 11.10 - 11.25 | Welcome and Introduction to Investigational Products | Welcome and Introduction to Regulatory Supply Chain | |||||||||||
| 11.25 - 12.05 | Keynote Address: 'So What Exactly Happened To Your
Shipment...?' Jason Wakelin-Smith, GCP Inspector, MHRA |
Keynote Address: 'What does GMP really Mean?' The Focused Pursuit of Meeting Regulatory Compliance Standards is really not Good Enough Richard Andrews, Operations Manager, MHRA Brendan Cuddy,Scientific Administrator, EMA |
|||||||||||
| 12.05 - 12.30 | Patient Survey - Interim Update Christine Milligan, ISPE Patient Survey Team |
||||||||||||
| 12.30 - 13.30 | Networking Break | ||||||||||||
| 13.30 - 13.45 | Introduction and Regulatory Forum |
|
|||||||||||
| 13.45 - 15.20 |
Experience With Managing Clinical Supplies from a Clinical Site Perspective Samantha Carmichael, Lead Pharmacist Clinical Trials, NHS Scotland |
||||||||||||
| 15.20 - 15.50 | Networking Break |
|
|||||||||||
| 15.50 - 17.00 | Introduction to Workshops
Workshop A IRT standardisation from sponsor’s perspective of logistics & terminology, front end and
site perspective Drug pooling and QP release - case Study and discussion Samantha Carmichael, NHS Scotland, Christine Milligan , ISPE Patient Survey Team |
|
|||||||||||
| 17.00 | Seminar Adjourns, Reception |
|
|||||||||||
| 08.30 - 08.40 | Introductions Esther Sadler-Wiliams, Catalent; Jim McKiernan, CEO, McKiernan Associates |
||
| 08.40 - 09.25 |
Keynote Presentation Industry Trends, and What can Pharma Learn from Other Industries? Colin Terry, Senior Manager, Deloitte |
||
| CLINICAL SUPPLY CHAIN | COMMERCIAL SUPPLY CHAIN | ||
| 09.30 - 09.40 |
Introductions and Summary of Chedia Abdelkafi, Head of Global CTS Planning, UCB Bernd Steffens, Head of Clinical Global Supplies Unit, Boehringer Ingelheim |
09.30 - 09.45 | Introductions and Summary of day 1 Jim McKiernan, CEO, McKiernan Associates |
| 09.40 - 10.00 | Introduction to ISPE and IP COP Henryk Junker, Quality Assurance Manager, Allergan |
09.45 - 10.30 | Effective Supply Chain Integrity through Process
Improvement Heike Falkenhagen, Boehringer Ingelheim |
| 10.00 - 10.40 | Ensuring Security of Clinical Supply Chain Tom Cochrane, Business Process Development Manager, Napp |
||
| 10.40 - 11.10 | Networking Break | ||
| 11.10 - 12.20 |
Workshop B Use of English -only labels on inner packs Hans Heesakkers, Senior Manager,Accenture Karen Gram,Technical Lead, Novo Nordisk
Perils and Pitfalls of Comparator Supply Julian Schultz, Associate Director Clinical Supplies, Takeda Robert Donnell, Head of Business Development, Durbin
Key Attributes of Simulation Tools Damian McEntegart,Senior Director, Statistics & Product Support Services, Perceptive Informatics Chedia Abdelkafi, Head of Global CTS Planning, UCB Pharma |
11.00 - 11.45 |
How Well Connected is the Pharmaceutical Supply Network? Nick Davies, CEO & Principal Consultant, NDA Consultants |
| 11.45 - 12.25 | Temperature Controlled TBC |
||
| 12.20 - 13.20 | Networking Break | ||
| 13.20 - 14.00 |
JIT Packaging and the Role of Pooling – true flexible solutions or potential complexity drivers? Helen Underwood, Client Services Director, Fisher |
13.15 - 13.55 | Cargo Risk Assessment - Rx360 - Supply Chain Security TBC |
| 14.00 - 15.00 | Workshop C | 13.55 - 14.35 |
Risk Evaluation N ia Evans, Head of Regulatory Affairs, Celesio –invited |
| 15.00 - 15.15 | Voting for themes for 2014, IP Closing Remarks |
14.35 - 15.15 |
Track-and Trace – Serialisation Fatma Taman, General Manager, Pharmavision |
| 15.15 - 15.45 | Networking Break | ||
| 15.45 - 17.15 |
PLENARY SESSION:
Regulatory Speakers - Guidelines Bryan Wright, ISPE Regulatory Advisor (Session Chair) Tony Orme, Senior GDP Inspector, MHRA Brendan Cuddy, Scientific Administrator, EMA UK Richard Andrews, Expert GMP/GDP, MHRA |
||
| 17.15 - 17.30 |
Discussion and Closing Remarks: Jim McKiernan, CEO, McKiernan Associates Bernd Steffens, Head of Clinical Global Supplies Unit, Boehringer Ingelheim Chedia Abdelkafi, Head of Global CTS Planning, UCB Pharma |
||
Thank you to our Top Tier Sponsors
Follow ISPE